“…Left ventricular (LV) and coronary angiography was performed using standard techniques just before revascularization. The size of the area at risk was estimated for each patient by measuring the circumferential extent of abnormally contracting segments (ACS) according to the method of Feild et al (16) and Lapeyre et al (17), as performed in previous randomized trials (11,18). Briefly, the length of the end-diastolic ventricular endocardial perimeter (circumference) and the length of the ACS of the enddiastolic perimeter were determined by computerized planimetry (Image J 1.38ϫ software).…”
“…Left ventricular (LV) and coronary angiography was performed using standard techniques just before revascularization. The size of the area at risk was estimated for each patient by measuring the circumferential extent of abnormally contracting segments (ACS) according to the method of Feild et al (16) and Lapeyre et al (17), as performed in previous randomized trials (11,18). Briefly, the length of the end-diastolic ventricular endocardial perimeter (circumference) and the length of the ACS of the enddiastolic perimeter were determined by computerized planimetry (Image J 1.38ϫ software).…”
“…Enzymatic activity of creatine kinase (CK) was measured, as described elsewhere, and total CK release was determined using the integrated appearance function curve with the individual disappearance constant, as described elsewhere. 5,12,13 Abnormality in wall motion was calculated by abnormally contracting segments, 14 global ejection fraction and regional ejection fraction, using the area method, 15 from the left ventriculogram at 30 days after onset of symptoms (ie, before hospital discharge). 5 To assess myocardial infarct size, 32 projections of single photoemission computerized The volume of defects was weighted for the average value of counts in the defect area, and this was defined as the extent of damaged myocardium in the total left ventricle or 'defect severity', as described elsewhere.…”
Section: Evaluation For Myocardial Salvage and Myocardial Lactate Metmentioning
These data, because of the wide interval between collection and current analysis, could have inherited historical bias. Nonetheless, they are also uniquely indicating the potential of CSI to induce not only immediate, but also clinically significant long-term, effects as an adjunct to reperfusion therapy. Therefore, CSI should be, once again, on the study agenda and be placed under contemporary and best-available scientific scrutiny.
“…In both groups, when full (TIMI > 2) reflow was not obtained, the patient was excluded from analysis (because infarct size assessment by CK release becomes invalid). A LV angiogram was obtained before re-opening of the occluded coronary artery in order to estimate the size of the area at risk, according to the method of Feild et al [10]. Area under the curve of CK release over the first 72 h of reperfusion was used as a Fig.…”
Section: Postconditioning: Toward a New Strategy For Treatment Of Amimentioning
Acute myocardial infarction is the leading cause of morbidity and mortality in industrialized countries. Ischemic postconditioning, that consists of repeated brief episodes of ischemia-reperfusion performed just after reflow following a prolonged ischemic insult, dramatically reduces infarct size in animal models. Recent data indicate that it might involve the activation of the PI3-kinase-Akt-eNOS as well as PKC signalling pathways and inhibition of the opening of the permeability transition pore. A recent clinical study demonstrated that postconditioning protects the human heart. Repeated brief episodes of inflation-deflation of the angioplasty balloon performed immediately after re-opening of the culprit coronary artery reduced infarct size by 36%. Additional studies are required to determine whether infarct size limitation by postconditioning would improve functional recovery as well as patient's outcome. Further research is needed to find new pharmacological agents that would mimick postconditioning in order to treat all patients with ongoing acute myocardial infarction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.